Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Internal Medicine
•
Chronic kidney disease
•
Nephrology
What is your approach to managing constipation in patients with chronic kidney disease?
Related Questions
How do you choose between the different vitamin D analogs for patients with CKD, an elevated PTH, and a normal 25-hydroxy vitamin D level?
Are there instances when you prefer serum creatinine over cystatin C when estimating GFR in a patient with CKD?
How often do you screen for cerebral aneurysms in patients with autosomal dominant polycystic kidney disease who do not have a family history of intracranial aneurysms or for whom the family history is unknown?
Would you consider using finerenone for proteinuric CKD associated with type 1 diabetes mellitus?
What are your criteria for starting tolvaptan in adult patients diagnosed with autosomal dominant polycystic kidney disease?
What is the optimal number of days to hold apixaban prior to a kidney biopsy or tunneled dialysis catheter placement?
How do you approach consults regarding clearance of patients with chronic kidney disease for surgery?
Do you recommend patients temporarily hold cilostazol prior to and after a kidney biopsy?
Are there instances when you recommend against a kidney biopsy in a patient with a single kidney who otherwise has indications for a biopsy, consents, and has no medical contraindications for the procedure?
At what serum bicarbonate level do you initiate alkali therapy for patients with chronic kidney disease?